Warsaw, Poland

Teresa Ryznar

This inventor holds 1 USPTO granted patent. Top assignee: Instytut Farmaceutyczny. Active years: 2010.


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Teresa Ryznar: Innovator in Pharmaceutical Chemistry

Introduction

Teresa Ryznar is a distinguished inventor based in Warsaw, Poland. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of pharmaceutical-grade compounds. Her innovative work has led to the development of a patented process that enhances the quality and purity of important pharmaceutical ingredients.

Latest Patents

Teresa holds a patent for a process titled "Process for preparation of pharmaceutically pure anhydrous calcipotriol." This process involves several key steps: first, dissolving crude calcipotriol in a solvent that forms an azeotropic system with water. Next, she obtains an intermediate calcipotriol by either evaporating the solution under reduced pressure or crystallizing it, depending on the water content. Finally, the intermediate is re-dissolved in an anhydrous solvent and crystallized to achieve pharmaceutical-grade anhydrous calcipotriol. This innovative method is crucial for ensuring the quality of pharmaceutical products.

Career Highlights

Teresa is currently employed at the Instytut Farmaceutyczny, where she continues to advance her research in pharmaceutical sciences. Her work has not only contributed to her personal achievements but has also had a positive impact on the pharmaceutical industry in Poland and beyond.

Collaborations

Throughout her career, Teresa has collaborated with notable colleagues, including Andrzej Kutner and Michal Chodyński. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Teresa Ryznar's contributions to pharmaceutical chemistry exemplify the importance of innovation in the development of high-quality pharmaceutical products. Her patented process for preparing anhydrous calcipotriol is a testament to her expertise and dedication to advancing the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…